Pembrolizumab combined with carfilzomib and low‐dose dexamethasone for relapsed or refractory multiple myeloma: Cohort 2 of the phase I KEYNOTE‐023 study

por Moreau, Philippe, Ghori, Razi, Farooqui, Mohammed, Marinello, Patricia, San Miguel, Jesus
Publicado 2021

Monoclonal antibodies targeting cell surface deposited complement fragment C3d potentiate cancer immunotherapy and eliminate antigen loss variants

por Skarzynski, Martin, Lindorfer, Margeret, Butera, Vicent, Vire, Berengere, Farooqui, Mohammed, Rader, Christoph, Taylor, Ronald, Wiestner, Adrian
Publicado 2015

Using high-sensitivity sequencing for the detection of mutations in BTK and PLCγ2 genes in cellular and cell-free DNA and correlation with progression in patients treated with BTK...

por Albitar, Adam, Ma, Wanlong, DeDios, Ivan, Estella, Jeffrey, Ahn, Inhye, Farooqui, Mohammed, Wiestner, Adrian, Albitar, Maher
Publicado 2017

Intercalated Disk Extracellular Nanodomain Expansion in Patients With Atrial Fibrillation

por Raisch, Tristan B., Yanoff, Matthew S., Larsen, Timothy R., Farooqui, Mohammed A., King, D. Ryan, Veeraraghavan, Rengasayee, Gourdie, Robert G., Baker, Joseph W., Arnold, William S., AlMahameed, Soufian T., Poelzing, Steven
Publicado 2018

P628: UPDATED ANALYSIS OF BELLWAVE-001: A PHASE 1/2 OPEN-LABEL DOSE-EXPANSION STUDY OF THE EFFICACY AND SAFETY OF NEMTABRUTINIB FOR THE TREATMENT OF B-CELL MALIGNANCIES

por Woyach, Jennifer, Flinn, Ian W., Awan, Farrukh, Eradat, Herbert, Brander, Danielle M., Tees, Michael, Parikh, Sameer, Phillips, Tycel, Ghori, Razi, Paydar, Ima, Farooqui, Mohammed Z. H., Byrd, John C., Stephens, Deborah
Publicado 2023

Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study

por Herman, Sarah E. M., Niemann, Carsten U., Farooqui, Mohammed, Jones, Jade, Mustafa, Rashida Z., Lipsky, Andrew, Saba, Nakhle, Martyr, Sabrina, Soto, Susan, Valdez, Janet, Gyamfi, Jennifer A., Maric, Irina, Calvo, Katherine R., Pedersen, Lone B., Geisler, Christian H., Liu, Delong, Marti, Gerald E., Aue, Georg, Wiestner, Adrian
Publicado 2014

Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study

por Gregory, Gareth P., Kumar, Shaji, Wang, Ding, Mahadevan, Daruka, Walker, Patricia, Wagner-Johnston, Nina, Escobar, Carolina, Bannerji, Rajat, Bhutani, Divaya, Chang, Julie, Hernandez-Ilizaliturri, Francisco J., Klein, Andreas, Pagel, John M., Rybka, Witold, Yee, Andrew J., Mohrbacher, Anne, Huang, Mo, Farooqui, Mohammed, Marinello, Patricia, Quach, Hang
Publicado 2022

The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy

por Landau, Dan A., Sun, Clare, Rosebrock, Daniel, Herman, Sarah E. M., Fein, Joshua, Sivina, Mariela, Underbayev, Chingiz, Liu, Delong, Hoellenriegel, Julia, Ravichandran, Sarangan, Farooqui, Mohammed Z. H., Zhang, Wandi, Cibulskis, Carrie, Zviran, Asaf, Neuberg, Donna S., Livitz, Dimitri, Bozic, Ivana, Leshchiner, Ignaty, Getz, Gad, Burger, Jan A., Wiestner, Adrian, Wu, Catherine J.
Publicado 2017

Direct in vivo Evidence for Increased Proliferation of CLL Cells in Lymph Nodes Compared to Bone Marrow and Peripheral Blood

por Herndon, Thomas M., Chen, Shih-Shih, Saba, Nakhle S., Valdez, Janet, Emson, Claire, Gatmaitan, Michelle, Tian, Xin, Hughes, Thomas E., Sun, Clare, Arthur, Diane C., Stetler-Stevenson, Maryalice, Yuan, Constance M., Niemann, Carsten U., Marti, Gerald E., Aue, Georg, Soto, Susan, Farooqui, Mohammed Z.H., Herman, Sarah E.M., Chiorazzi, Nicholas, Wiestner, Adrian
Publicado 2017